2018 annual financial data
Protagonist Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was -161.51%.
Operating income was -42,269,000 USD and net income was -38,924,000 USD.
Operating cash flow was -49,947,000 USD.
Get free Protagonist Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 30,925,000 USD
- Operating income
- -42,269,000 USD
- Net income
- -38,924,000 USD
- Operating cash flow
- -49,947,000 USD